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Zhen Chen,4 and Sheng Zhong1,7,*SUMMARY
We developed the Rainbow-seq technology to trace cell division history and reveal single-cell tran-
scriptomes.With distinct fluorescent protein genes as lineagemarkers, Rainbow-seq enables each sin-
gle-cell RNA sequencing (RNA-seq) experiment to simultaneously decode the lineage marker genes
and read single-cell transcriptomes. We triggered lineage tracking in each blastomere at the 2-cell
stage, observed microscopically inequivalent contributions of the progeny to the two embryonic
poles at the blastocyst stage, and analyzed every single cell at either 4- or 8-cell stage with deep
paired-end sequencing of full-length transcripts. Although lineage difference was not marked un-
equivocally at a single-gene level, it became clear when the transcriptome was analyzed as a whole.
Moreover, several groups of novel transcript isoforms with embedded repeat sequences exhibited
lineage difference, suggesting a possible link between DNA demethylation and cell fate decision.
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A central question to developmental biology is how cells break molecular and functional symmetry during
mitotic divisions. Two models have been proposed (Altschuler and Wu, 2010). In one model, a progenitor
cell first divides into a set of homogeneous cells, and then these homogeneous cells exhibit different ten-
dencies toward different routes of differentiation (homogeneous model). In the other model, every division
creates a pair of cells with slight differences in their molecular profile, and accumulation of these differ-
ences leads to cell fate commitment (non-homogenous model).
Mammalian preimplantation development from a zygote to a blastocyst consisting of the functionally
differentiated inner cell mass (ICM) and trophectoderm (TE) (Wolpert, 2015) is a perfect example of the
symmetry-breaking paradigm (Gardner, 2001; Zernicka-Goetz et al., 2009). The first cell fate decision in
mammals was believed to be an example of the homogeneous model (Hiiragi et al., 2006). After fertiliza-
tion, a mouse zygote was thought to undergo two or more rounds of symmetric cell divisions, which create
four or more homogeneous embryonic cells (blastomeres) (Leung and Zernicka-Goetz, 2015; Motosugi
et al., 2005). These homogeneous cells further divide and through a stochastic process (Wennekamp
and Hiiragi, 2012) eventually self-organize into ICM and TE (Wennekamp et al., 2013) (Figure 1A). However,
recent work on single-cell transcriptome profiling reported reproducible inter-blastomere gene expression
differences in 2- and 4-cell mouse embryos (Goolam et al., 2016; Biase et al., 2014; Burton et al., 2013;
Piotrowska-Nitsche et al., 2005; Shi et al., 2015), offering support to the non-homogeneous model (Vogel,
2005; Hiiragi and Solter, 2006).
The critical missing information for using single-cell transcriptome profiling to test the competingmodels is
the history of cell divisions (Goolam et al., 2016; Plachta et al., 2011; Torres-Padilla et al., 2007; Rodriguez-
Terrones et al., 2018). We approached the challenge of connecting cell-to-cell transcriptome differences
at later embryonic stages to progenitor cells by developing Rainbow-seq, which combines cell division
lineage tracing (Tabansky et al., 2013) with single-cell RNA sequencing.
Advances in cell-specific genomic barcodes are revolutionizing cell lineage tracing. Leveraging genome
editing tools (McKenna et al., 2016; Kalhor et al., 2017; Perli et al., 2016) (Raj et al., 2018) or combinatorial
DNA recombination loci (Polylox) (Pei et al., 2017), researchers were able to insert cell-specific exogenous16 iScience 7, 16–29, September 28, 2018 ª 2018 The Authors.
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Figure 1. Competing Models and Lineage Tracking Strategy
(A) Homogeneous and non-homogeneous hypotheses differ in whether the 2 blastomeres at 2-cell stage have identical tendencies to contribute their
descendant cells to inner cell mass (brown) and trophectoderm (blue-gray).
(B) Cell lineage tracing was enabled by creation of preimplantation embryos heterozygous for Brainbow sequence and Cre and induction of Cre at 2-cell
stage. At blastocyst stage, activated Brainbow genes can exhibit either relatively equal (balanced) or biased (unbalanced) distributions in inner cell mass and
trophectoderm. The equal and biased distributions would lend support to the homogeneous and the non-homogeneous hypotheses respectively.DNA barcodes to the genomes of progenitor cells. The lineage information is propagated by DNA
duplication and can be recovered in the progeny by targeted sequencing of the engineered genomic
sequences. We reasoned that combining lineage-specific genomic barcodes and single-cell RNA
sequencing (RNA-seq) would reveal single-cell transcriptome together with cell division lineage. To maxi-
mize the chances of obtaining expressible genomic barcodes, we resorted to the well-tested Brainbow-2.1
construct that can express one of four fluorescent protein genes (green fluorescent protein [GFP], cyan fluo-
rescent protein [CFP], red fluorescent protein [RFP], yellow fluorescent protein [YFP]) (Livet et al., 2007).
These fluorescent protein genes interspersed with recombination sites serve as both genomic barcodes
and expressible cell markers. Their expression can be examined microscopically, offering an intermediate
step of validation before single-cell RNA-seq analysis.
RESULTS
Cell Lineage Tracing Starting with 2-Cell Embryos
We generated mouse embryos by crossing a strain that is homozygous for the Brainbow sequence (Cai
et al., 2013) with a mouse strain that is homozygous for a tamoxifen-inducible Cre recombinase gene (Fig-
ure 1B). Tamoxifen treatment was expected to induce CRE translocation to the nucleus, which in turn could
induce recombination on loxP sites, and thus lead to activation of one and only one of the four fluorescent
protein genes in the Brainbow sequence (Cai et al., 2013). We tested whether these anticipated effects
could be achieved by a short application of tamoxifen to early 2-cell embryos (Figure S1A). Upon collection
of early 2-cell embryos (42 hours post injection) and a 2-hr 4-hydroxytamoxifen treatment, CRE protein
translocated to the nuclei (Figure S1B), and within 1 hr post treatment the nuclear concentration of CRE
reduced to the background level (Figure S1B). Embryos that underwent this brief tamoxifen treatment ex-
pressed fluorescent proteins at later developmental stages including 4-cell, 8-cell, and blastocyst stages
(Figure 2A). Hereafter, we name these early 2-cell-stage hybrid embryos that undergo a 2-hr 4-hydroxyta-
moxifen treatment as rainbow embryos, and the Cre-activated genes as lineage marker genes.
Daughter Cells of Blastomeres at 2-Cell Stage Tend to Contribute Inequivalently to
Embryonic and Abembryonic Poles at the Blastocyst Stage
We leveraged the Brainbow embryos to revisit the question whether the descendant cells produced by
each blastomere of a 2-cell embryo contribute equivalently to embryonic and abembryonic poles in blas-
tocyst-stage embryos (Hiiragi and Solter, 2004; Plusa et al., 2005; Vogel, 2005). Our experiment was de-
signed as follows. First, a total of N blastocyst-stage rainbow embryos would be imaged by a wide-field
fluorescent microscope with filters for GFP, RFP, and DAPI (Figures 2A and 2B). Because we had to devote
one of three channels to nuclei staining (DAPI) for cell counting, this experimental design would not be able
to detect CFP- and YFP-expressing cells. Next, the imaged embryos with more than one-third of their cells
in the embryonic pole expressing a detectable lineage marker (either GFP or RFP) would be used for data
analysis. A contingency table would be built for each embryo documenting the numbers of GFP-expressing
(GFP+) and non-GFP-expressing (GFP-) cells in the embryonic pole and in the abembryonic pole. An odds
ratio (OR) would be calculated for each embryo, and if 1/3 < OR < 3, this embryo would be regarded
as having balanced GFP+ cells in the two poles, otherwise the embryo would be regarded as having
unbalanced GFP+ cells in the two poles. The same analysis would be carried out for RFP.
We imaged 18 early blastocysts expressing RFP and/or GFP, of which 12 embryos had more than one-third
of cells expressing fluorescent protein. Eight of these embryos (66%) exhibited unbalanced GFP+ or RFP+
cells in the two poles (first column, Figure 2C). For sensitivity analyses, we used two alternative counting
methods to re-estimate the proportion of embryos with unbalanced distribution of cell lineage between
the two poles. First, we required the embryos to be included for analysis to have at least 50% of its cells
expressing either GFP or RFP, resulting in a total of 9 embryos, of which 6 embryos (66%) exhibited unbal-
anced GFP+ or RFP+ cells in the two poles (second column, Figure 2C). Second, we counted the GFP+ cells
in the embryonic pole (n1) and GFP+ cells in the abembryonic pole (n2) and regarded any embryo with18 iScience 7, 16–29, September 28, 2018
Figure 2. Cell Lineage Tracking in Mouse Preimplantation Embryos
(A) Recombination of Brainbow construct was induced in early 2-cell embryos, and images were acquired at 4-cell,
8-cell and blastocyst stages. GFP: GFP, green fluorescent protein; RFP, red fluorescent protein; DIC: differential
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Figure 2. Continued
interference contrast. Scale bar: 15 mm. Images were acquired by a wide-field microscope containing filters for RFP
and GFP.
(B) Two representative blastocyst-stage embryos imaged with DIC, DAPI, GFP, and RFP channels.
(C) Numbers of blastocyst-stage embryos with balanced (orange) and unbalanced (blue) lineage marker expression in the
two embryonic poles, with respective counting methods (three lanes). Data from different counting methods are shown in
columns, which include the method requiring at least 1/3 cells (one-third) or 1/2 cells (half) expressing either GFP or RFP,
and the method of counting all the imaged embryos (all).
See also Figure S1.1/3 <n1/n2< 3 as having balanced GFP+ cells, and did the same counting for RFP. All 18 embryos were
included in this analysis, of which 13 embryos (72%) were unbalanced (third column, Figure 2C). Taken
together, approximately two-thirds of rainbow embryos exhibited unbalanced distribution of the two
cell lineages in the two embryonic poles. Previous efforts obtained discrepant estimates of such a propor-
tion (Piotrowska et al., 2001; Hiiragi and Solter, 2004; Plusa et al., 2005; Vogel, 2005). Our results obtained
from rainbow embryos were better aligned with those suggestingmore embryos exhibiting unequal contri-
bution of the two lineages than those exhibiting equal contribution to the embryonic and abembryonic
poles. These microscopic analyses confirmed that the recombination strategy introduced lineage-specific
expressible marker genes and served as a sanity check for downstream Rainbow-seq analyses.
Single-Cell RNA Sequencing Analysis of Rainbow Embryos
We induced lineage tracking from 2-cell stage and carried out Rainbow-seq on nine 4-cell embryos and
four 8-cell embryos. We lost one blastomere from an 8-cell embryo during the manipulation. We combined
the Smart-seq2 full-length RNA-seq protocol (Picelli et al., 2014) with deep paired-end sequencing and
produced paired-end 100-nt sequencing data from a total of 67 single blastomeres, including 36 from
4-cell stage and 31 from 8-cell stage (Tables S1 and S2). One 8-cell-stage blastomere did not pass our qual-
ity control as it produced fewer than 3 million uniquely mapped sequencing read pairs (Row E13, B7,
Table S2). The remaining 66 cells yielded on average 21 million uniquely mapped read pairs (mm10) per
cell (Figure S2A). We used single-cell RNA-seq reads mapped to the Brainbow-2.1 sequence to determine
which lineage marker gene was expressed and categorized the cells from each embryo into two groups
(lineage A and B) based on its expressed marker gene (Lineage column, Tables S1 and S2). Data were insuf-
ficient to resolve three 4-cell-stage embryos (12 blastomeres) and four 8-cell-stage blastomeres due to
limited sequencing reads mapped onto any lineage marker gene. We deposited all sequencing data
into GEO (GSE106287) for public access; however, we limited our analyses to the 50 blastomeres whose
lineage can be traced to either one of the sister blastomeres at the 2-cell stage.
The first two principle components explained 8% of sample variations, where the developmental stage was
a major source of variation (Figure S2B). With Fragments Per Kilobase of transcript per Million mapped
reads (FPKM) >1 as the threshold for calling expressed genes, the 4-cell-stage blastomeres on average ex-
pressed 6,852 coding genes per cell. A total of 15,218 coding genes were expressed in at least one 4-cell-
stage blastomere. The 8-cell blastomeres on average expressed 6,474 coding genes per cell, with a total of
15,342 coding genes expressed in at least one 8-cell blastomere.
Transcriptome-wide Expression Difference between Cell Division Lineages
Recognizing that data of individual genes may not provide conclusive evidence to either the homogeneous
or the non-homologous model, we analyzed data of the entire transcriptome. We carried out two transcrip-
tome-wide tests. First, we tested whether there is non-zero probability for any subset of genes to exhibit
greater between-lineage variation than embryo-to-embryo variation. To this end, we fit a generalized linear
model to every gene (g) and calculated the sum of squares to account for the between-lineage variation
ðSSglineage Þ and embryo-to-embryo variation ðSSgembryoÞ. For every gene, we calculated the ratio ðrgÞ of line-
age sum of squares to combined sum of squares of embryo and lineage. The empirical distribution of this
ratio (denoted as R) exhibited greater tail probabilities than a series of three b distributions, b(2,5), b(1,3),
and b(5,5), each of which has non-zero probability in any non-singular interval near 1 ([1-d,1],(d> 0)) (Figures
3A–3D). The non-zero probability for a subset of genes to exhibit greater lineage variation than embryo
variation suggests a transcriptome-wide difference between the two division lineages.
Second, after a gene-by-gene test of the null hypothesis that this gene does not exhibit between-lineage
expression differences (ANOVA, Transparent Methods), we obtained the empirical distribution of the20 iScience 7, 16–29, September 28, 2018
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Figure 3. Transcriptome-wide Differences between Two Lineages
(A and B) Empirical distributions of random variable R (ratio of between-lineage variation to combined variation) in 4-cell (A) and 8-cell-stage (B) embryos,
superimposed with a series of b distributions [red: b(1,3), blue: b(2,2), green: b(5,5)].
(C and D) Q-Q plots of R versus a series of b distributions in 4-cell (C) and 8-cell (D) stage embryos, where red, blue, and green represent b(1,3), b(2,2), and
b(5,5), respectively.
(E and F) Distributions of q-values from lineage equivalence tests based from real data (red) and shuffled data (blue) in 4-cell (E) and 8-cell-stage
(F) blastomeres.
See also Figure S2 and Tables S1 and S2.q-values for all the genes from such a test (red bars, Figures 3E and 3F). To derive a background distribution,
we shuffled the lineage labels on every blastomere and carried out the same test (blue bars, Figures 2E
and 2F). The distribution of q-values from real data was skewed toward lower values when compared with
the q-values from shuffled data (p value < 2.2 3 1016, Kolmogorov test), reflecting a transcriptome-wide
difference between the two cell division lineages.
Specific Genes with Expression Differences between Cell Division Lineages
The genes with the largest between-lineage differences in transcript abundance at 4-cell stage were
involved in the basic transcription machinery including Gtf2f1 (General Transcription Factor IIF Subunit 1,
TFIIF) and Eloa (RNA Polymerase II Transcription Factor SIII Subunit A1, SIII), negative regulations of P53
activity (Aurkb) and WNT signaling (Ctnnbip1, Inhibitor of Beta-Catenin and Tcf4), nuclear pore complex
(Nup35), protein synthesis in cytoplasm (Rbm3) and mitochondrion (Mrpl10), endoplasmic reticulum (ER)
biogenesis (Atl2), and glycogen synthesis (Fbp2) (Figure 4A). The genes with the largest between-lineage
variations at 8-cell stage were transcriptional suppressors Bclaf1 and Smad7, the chromatin remodeler Atrx
involved in deposition of H3K9me3, histone demethylase Kdm2b related to removal of active histonemarks
including H3K4me3, vesicle trafficking and secretory pathways including Golgi membrane proteins Glg1
and B4galnt2, trans-Golgi network, Snx15 and Golgi-to-ER transport Stx8 (vesicle fusion, Golgi-to-ER trans-
port), cell shape modulator Fez2, and the lincRNA genesGm12514 andGM14617 (Figure 4B). Interestingly,
suppression of H3K4 demethylase Kdm2b in mouse oocytes resulted in impaired blastocyst formation (see
extended Figure 6E in Liu et al. (2016)). Even though the above-mentioned genes appeared to support the
non-homologous model, the absolute expression difference is small (Figure 4) and statistical significance is
obscure due to limited sample size and multiple comparisons. At this point, it became clear that the sta-
tistical tests based on the entire transcriptome (Figure 3) served to better evaluate the two competing
models than any possible test based on any individual gene.
Transposon-Related Novel Transcript Isoforms
We tested whether any novel transcript isoforms were specifically expressed in early-stage preimplantation
embryos. To this end, we combined all the Rainbow-seq datasets to obtain over 2.1 billion paired-
end reads, of which over 1.6 billion read pairs could be uniquely mapped to the genome (mm10). Using
Cufflinks (v2.2.1 with g parameter), we recorded a total of 20,371 novel transcript isoforms, corresponding
to 7,594 annotated genes. Among these novel isoforms, 3,632 (17.8% of all novel isoforms) contained trans-
poson sequences according to Repeatmasker database (February 2015 release) (Figure 5A), which will be
referred to as Transposon Related Novel Isoforms (TRENI). These 3,632 TRENIs corresponded to 1,701
Refseq genes, in which ‘‘poly(A) RNA binding,’’‘‘RNA binding,’’ ‘‘nucleotide binding,’’ and ‘‘nucleic acid
binding’’ were enriched (Benjamini adjusted p value < 1.1 3 107; Gene Ontology functions [DAVID
v6.8]) (Figure 5B), suggesting a recurring theme in RNA binding and processing.
We asked whether the incorporation of these transposons in TRENIs were supported by junction reads
spanning across the transposon and the nearest known Refseq exons. To this end, we computed the ratio
of junction reads and the total number of reads aligned to each transposon, hereafter denoted as junction
ratio (JR, Transparent Methods). We identified 3,902 transposons contained in TRENIs, of which 2,817
(72.19%) exhibited a JR of 0.9 or above (Figure 5C).
To test whether TRENIs exhibit between-lineage expression difference, we derived a q-value for each of
the 3,632 TRENIs by ANOVA (Transparent Methods). For comparison, we shuffled the lineage labels on
all blastomeres and derived q-values again (background q-values). The distribution of real data q-values
differed with that of background q-values (p value < 2.2 3 1016, Kolmogorov test) (Figures 5D, 5E,
and S3). More importantly, a total of 37 TRINEs exhibited q-values less than 0.01, whereas none of the
background q-values were less than the same threshold (Figure S3). Finally, all the repeats expressed in22 iScience 7, 16–29, September 28, 2018
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Figure 4. Genes with differential expression between two lineages.
Genes with the between-lineage differences at 4- (A) and 8-cell (B) stages. FPKM (y axis) of every blastomere (column) in each embryo (marked
by embryo number in columns). Shaded columns delineate different embryos. The blastomeres of the two lineages are marked with A (red) and
B (blue).4- and 8-cell embryos, regardless of whether they were contained within TRINEs, did not exhibit statistically
discernable between-lineage differences (the distribution of q-values derived from real data was not
different from that of shuffled data) (Figure S4).
Murine Alu Makes the Largest Contribution to Novel Transcript Isoforms
We asked whether different repeat families contributed equally to TRENIs. In the total of 58 repeat families
(RepeatMasker) 18 families had 20 or more genomic copies included in TRENIs (Figure 5F). To account for
genome-wide copy numbers of each repeat family, we calculated the OR for each repeat family to be con-
tained in TRENIs. When repeat families were ranked by this OR, murine Alu, B4, ID, and B2 were most en-
riched in TRENIs (Figure 5G). We asked whether the association between any repeat family and TRENIs
would became more pronounced when only high-confidence transposon-containing TRENIs were
included in the analysis. To this end, we repeated the above analysis using only the 2,817 transposons
with JRR 0.9, which resulted in similar ORs with Alu being the most enriched repeat family (Figure S5).
Next, we asked whether different repeat families contributed equally to TRENIs’ 50 UTR. There were a total
of 673 (18.53%) TRENIs in which the transposons were inserted in the 50 upstream to previously annotated
start codons (50 UTR-TRENIs) (Figure 5H), among which 418 contained murine Alu, simple repeat, low
complexity, and B4 and B2 repeats in 50 UTRs, where murine Alu alone accounted for more than three hun-
dred 50 UTRs (Figure 4H). We calculated the OR to quantify the association of transposons in each trans-
poson family to 50UTR-TRENIs. Murine Alu exhibited the largest enrichment to 50 UTRs in these novel tran-
script isoforms (OR = 3.03, p value = 0, chi-square test) (Figure 4H). In contrast, the other repeat families
exhibited either moderate enrichment (1 < OR <1.5) or depletion (OR <1) in 50 UTR-TRENIs (Figure 5I).
Finally, 9 and 26 50 UTR-TRENIs exhibited expression differences between the two division lineages at
4- and 8-cell stages, respectively, including novel transcript isoforms of Gata4 (Figure S6A) and Khdc1a
(Figure S6B).
DISCUSSION
Lack-of-Continuity Dilemma
Not a single gene has been reported to exhibit continuous between-lineage expression difference
starting from the two blastomeres at 2-cell stage until the formation of ICM and TE at blastocyst stage.
This is not completely unexpected considering that comprehensive transcriptome analyses revealed
highly dynamic gene transcription in early-stage mouse preimplantation embryos (Kidder and Pedersen,
1982; Xie et al., 2010), likely attributable to combined effects of cleavage-related split of RNA pool, RNA
degradation, and zygotic genome activation (Biase et al., 2014). The lack of identified single gene(s) with
continuous expression divergence posed a dilemma to the non-homologous hypothesis, in that if the
two blastomeres at 2-cell stage are poised for cell fate decisions, what could to be the molecular means
to record and later exhibit such a difference? Hereafter we call this dilemma the lack-of-continuity
dilemma.
Reconciliations to Lack-of-Continuity Dilemma
The dilemma was rooted in the non-homogenous model andmay be resolved in several ways. First, the cell
fate decision is initiated after the first cleavage. This idea essentially refutes the non-homogeneous model
for the first cleavage. Second, the lineage difference is passed from one gene activated at an earlier stage,
for example, 2-cell stage, onto another gene activated at a later stage. Given that the transcription rate and
mRNA half-life are both an order of magnitude smaller than the time of a cleavage, this model is within the
boundaries of biophysics principles. Third, the lineage difference is recorded in the order of expression
levels of a pair or list of genes, and this order is preserved throughout preimplantation development.
For example, at 2-cell stage the expression level order is A > B in one blastomere and B > A in the other
blastomere, and such an order is preserved in the ICM and TE. The third explanation was supported by
single-cell RNA-seq data (Biase et al., 2014). Taken together, there are plausible means to explain the
dilemma while withholding the homologous model.24 iScience 7, 16–29, September 28, 2018
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Figure 5. Transposon Related Novel Isoforms (TRENIs)
(A) Pie chart of novel transcript isoforms, including 16,739 that do not contain any repeat sequence (gray) and 3,064 and
673 isoforms with transposons located downstream to start codons (blue) and in 50 UTRs (yellow).
(B) Enriched GO molecular functions in TRENIs, ranked by multiple hypothesis testing adjusted p values.
(C) Histogram of junction ratios for all TRENI-containing transposons.
(D and E) Histogram of TRENIs’ q-values derived from tests of equivalent expression between lineages at 4- (D) and 8-cell
(E) stages, based from real data (red) and shuffled data (blue).
(F) Copy number of repeats contained in TRENIs, categorized by transposon family (columns).
(G) Odds ratios between TRENIs and each repeat family (columns). Vertical bars: 95% confidence intervals. Odds ratio was
not calculated for those repeat families when the TRENIs associated with a repeat family were fewer than 20.
(H) Copy number of repeats contained in TRENIs’ 5 UTRs, categorized by transposon family (columns).
(I) Odds ratios between 50UTR-TRENIs andeach repeat family (columns). Vertical bars: 95% confidence intervals. Odds ratiowas
not calculated for those repeat families when the 50UTR-TRENIs associated with a repeat family were fewer than 20.
See also Figures S3–S6.The Rainbow-seq Approach
Rainbow-seq addresses the lack-of-continuity dilemma fromanother perspective. Themain idea is to combine
cell division tracing with single-cell RNA-seq. A genetic cell-lineage tracer was activated at 2-cell stage and
analyzed at later stages. Thismethod has two advantages. First, activation of distinct tracer genes in each blas-
tomere’s genomewas achieved by a relatively simple procedure. Second, through a genetic tracer embedded
in the genome, DNA duplication ensured inheritance of the tracer during cell divisions. We used Rainbow-seq
to test the consequential events of two cell division lineages created by the first cleavage.
The Lineage Difference Lies in the Collective Behavior of Many Genes
When each gene is individually analyzed, even the most significant genes only exhibited small expression
differences between the lineages (Figure 4). However, the difference of the two lineages became clear
when the entire transcriptome was analyzed as a whole. In other words, the collective distribution of tran-
scriptome exhibited a significant difference in the two cell division lineages (Figure 3). This observation
has important implications. On the one hand, it repeated once again the negative results of previous studies
that not a single gene exhibited clear difference between the two division lineages created by the first cleav-
age. On the other hand, the two division lineages in fact exhibit pronounced difference, which lies in the in-
tegral expression of many genes. To translate this difficult concept, we would like to make an analogy that
‘‘the individual seed beads all look similar, but two bead-woven crafts can exhibit very different patterns.’’
Recent studies have reported inter-blastomere expression difference of several specific genes at the 4-cell
stage or later stages (Biase et al., 2014; Burton et al., 2013; Piotrowska-Nitsche et al., 2005). This study
pushed the initiation time point of between-blastomere difference to the 2-cell stage. The top-ranked
genes with between-lineage differences appeared to emphasize a theme of negative regulation, including
inhibitors of the WNT pathway Ctnnbip1 (Inhibitor of Beta-Catenin and Tcf4) (Tago et al., 2000) and Smad7
(Han et al., 2006), aurora kinase B that negatively regulates P53’s transcriptional activity by promoting
its degradation (Gully et al., 2012), chromatin remodeler Atrx that promotes repressive histone mark
H3K9me3 and formation of heterochromatin (Sadic et al., 2015), histone demethylase Kdm2b that removes
active histone mark H3K4me3 (Tsukada et al., 2006), and glycosyltransferase B4galnt2 involved in negative
regulation of cell-cell adhesion (Kawamura et al., 2005) (Figure 4). Considering that negative feedback as
exemplified in Delta-Notch signaling is perhaps the best known molecular mechanism for neighboring
cells to take on divergent functions (Artavanis-Tsakonas et al., 1999), the emergence of negative regulators
from Rainbow-seq analysis may allude to cell-cell communication between the first two cell lineages. The
other emerged theme of vesicle trafficking and secretion as exemplified by Atl2, Glg1, B4galnt2, Snx15,
and Stx8 is consistent with the idea of cell-cell communication at very early embryonic stages (Calarco-Gil-
lam, 1986) (Sozen et al., 2014). Finally, Fbp2’s divergent presence in the two lineages is reminiscent of a
sperm-related embryo patterning hypothesis (Zernicka-Goetz, 2002; Takaoka and Hamada, 2014), consid-
ering the presence of Fbp2 mRNA in mouse sperm (Schuster et al., 2016) and interactions of FBP2 and
ALDOA, a sperm-head protein essential for sperm-egg interaction (Petit et al., 2013).
Contribution of Transposon Related Novel RNA Isoforms (TRENI) and DNADemethylation to
Lineage Difference
A group of novel transcript isoforms of known genes that contained repeat sequences, called TRENIs,
exhibited lineage difference, especially at the 8-cell stage (Figure 5D). The lineage difference is more26 iScience 7, 16–29, September 28, 2018
Figure 6. A Model of Repeat Sequence-Related Lineage Difference
Decrease of modified cytosine (filled circles) allows repeat sequence (yellow) to be expressed (A). Atrx is expressed in one lineage where ATRX preferentially
attaches to hypomethylated (empty circles) repeats and suppresses their expression (B).pronounced in each group of TRENIs (Figures 5D and 5E) than an individual TRENI (Figure S6), reinforcing
the idea that lineage difference at such early stages of development is marked by the cumulative behavior
of many genes. At 8-cell stage, chromatin remodeler Atrx that responds to DNA demethylation and sup-
presses the expression of hypomethylated repeat sequence in preimplantation embryos (He et al., 2015)
exhibited between-lineage expression difference (Figure 4B). These data suggest a model where DNA
demethylation on repeat sequence is asymmetrically compensated by ATRX in the two cell lineages, lead-
ing to differential expression of transposon-containing transcripts (Figure 6). Murine Alu repeats were most
enriched in TRENIs, and the murine Alu family was the only repeat family with significant enrichment at the
50UTR of TRENIs. These expression data may offer an explanation to the selective retention of Alu repeats
to upstream and intronic regions of known genes (Tsirigos and Rigoutsos, 2009), where the selectively re-
tained Alu repeats are part of rare transcript isoforms, which are specifically expressed in preimplantation
embryos. Furthermore, asymmetric suppression of these repeats leads to asymmetric expression of genes
required for the first cell fate decision, which is the functional force for selective retention. Consistent with
this idea, the same group of genes involved in ‘‘RNA binding’’ were enriched in TRENIs and were reported
by an independent analysis as the neighboring genes to selectively retained Alu repeats (Tsirigos and
Rigoutsos, 2009). However, the other transcripts of repeat sequences that were expressed in preimplanta-
tion embryos (Rodriguez-Terrones and Torres-Padilla, 2018) but not contained within TRENIs did not
exhibit statistically discernable lineage differences (Figure S4).
Limitations of the Study
Tradeoff between the Number of Embryos and Sequencing Depth
Our experimental design was determined by our analysis goals. The goals of identifying potentially
very small inter-blastomere differences and novel transcript isoforms required deep paired-endiScience 7, 16–29, September 28, 2018 27
sequencing of full-length transcriptome in single cells. Most single cells in this study produced 20 to
30 million uniquely mapped 100-nt read pairs, which are 40–60 million uniquely mapped 100 nt
reads per cell. Sequencing cost remains a limitation at this sequencing depth. If future applica-
tions do not care about transposon-produced transcripts or novel RNA isoforms, further experi-
ments can significantly reduce the sequencing depth, use single-end sequencing, and even replace
with other protocols that do not sequence full-length transcripts. As a tradeoff, more single cells can
be sequenced.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
DATA AND SOFTWARE AVAILABILITY
The GEO accession number for the data reported in this paper is GEO: GSE106287.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Transparent Methods, six figures, and two tables and can be found with
this article online at https://doi.org/10.1016/j.isci.2018.08.009.
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Transparent Methods 
Generation of rainbow mouse embryos 
All the procedures for animal handling and breeding were approved by Institutional Animal Care 
and Use Committees of University of California San Diego. For the generation of rainbow 
embryos, we crossed two transgenic strains obtained from Jackson Laboratory. The strain 
STOCK Gt(ROSA)26Sortm1(CAG-Brainbow2.1)Cle/J (stock number 013731, 
RRID:SCR_004894) is homozygous for one copy of the brainbow construct v2.1, and the strain 
STOCK Tg(CAG-cre/Esr1*)5Amc/J (IMSR Cat# JAX:004453, RRID:IMSR_JAX:004453) is 
homozygous with one copy of the gene coding CRE protein. We crossed mice from each of the 
strains (1:1) to generate hybrid embryos containing one copy of the brainbow construct v2.1 and 
one copy of the Cre gene. 
Adult female mice were estrous-synchronized and super-ovulated by two consecutive intra-
peritoneal injections of hormones (to 2.5 IU of hCG and 5IU of PMSG, PG600, Intervet). The 
injections were administered 48 hours apart, and following the second injection, females and 
males were mated (1:1). Two-cell embryos were collected 46 hours post second hormonal 
injection (hpi) and incubated (37°C, 5%CO2, 100% humidity) for two hours with 4-
Hydroxytamoxifen (100µm, Sigma) in KSOM media (Millipore).  
 
Embryo imaging 
Tamoxifen-treated embryos were cultured in vitro (37°C, 5%CO2, 100% humidity) until reaching 
4-cell, 8-cell or blastocyst stages (~ 54, 70 and 90hpi, respectively), briefly treated with 
NucBlueTM Live Cell Stain (Invitrogen) in KSOM media and taken to wild-field inverted 
fluorescent microscope (Olympus). Embryos were imaged in KSOM media, with filter cubes for 
DAPI (Ex: 350/50x, Em: 460/50m), GFP (Ex: 480/40x, Em: 535/50m), RFP (Ex: 545/25x, Em: 
605/70m) and differential interference contrast, and a 40x dry objective (NA=0.95, 
WD=0.18mm). Images were captured with an ORCA R2 monochromatic CCD camera 
(Hamammatsu) at 2µm spacing intervals in the z-axis, and rendered in MetaMorph software 
(Molecular Devices). Images were further evaluated in ImageJ software (Schneider et al., 2012). 
 
Immunocytochemistry assay 
Tow-cell embryos were fixed in methanol at −20°C overnight, washed in PBS (supplemented 
with 0.1% BSA), and incubated for 5 min in permeabilization solution (PBS, 0.1% BSA, 0.1% 
Triton X-100). Embryos were then incubated for 1 h in blocking solution (PBS, 0.1% BSA, 10% 
bovine fetal serum), following incubation with Monoclonal Anti-Cre antibody (Sigma-Aldrich Cat# 
C7988, RRID:AB_439697, 1:100 dilution in blocking solution) for 2 h at room temperature. After 
three PBS (0.1% BSA) washes, indirect detection was possible by immersing the embryos in 
blocking solution with Goat Anti-Mouse IgG1 (y1) Antibody, Alexa Fluor 594 Conjugated 
(Innovative Research Cat# 322588, RRID:AB_1502303, 1:500 dilution). Following three washes 
with PBS (0.1% BSA), embryos were immersed in blocking solution containing Mouse anti-
Tubulin-Alexa-488 (Innovative Research Cat# 322588, RRID:AB_1502303, 1:25dilution) for 1 h. 
Embryos were washed in PBS (0.1% BSA) supplemented with NucBlue Fixed Cell Stain 
ReadyProbes (Invitrogen), and preserved with Prolong Gold (Invitrogen). Embryos were 
scanned with a Fluoview FV1000 confocal microscope (Olympus), with the aid of a 40× oil 
objective. 
 
Assessment of color-coded distribution of cells in blastocysts 
Blastocyst images were visually inspected by one investigator. Cells were identified with the by 
their nucleus staining with DAPI. The cells were classified according to two criteria: First, cells 
were assigned to the embryonic (em) or abembryonic (abe) pole of the embryo. Second, the 
cells were color coded as red, green or no-color.  
 
Single-cell RNA-sequencing 
Four- (n=9) and 8-cell (n=4) embryos imaged and having two or more cells expressing at least 
one of the fluorescent proteins (RFP or GFP) were subjected to single-cell RNA-sequencing. 
Embryos were briefly treated with Tyrode’s acid solution (Sigma) for removal of zona pelucida. 
The embryos were washed in PBS and incubated in Trypsin solution (Invitrogen) with RNase 
inhibitor (1IU/µl, Clontech) and BSA (50μg/µl) for the separation of the blastomeres. The 
blastomeres were separated by gentle pipetting, washed in PBS supplemented with RNase 
inhibitor and BSA, and snap frozen in individual micro-centrifuge tubes. 
We amplified the cDNA of individual blastomeres according to the SMART-seq2 protocol (Picelli 
et al., 2014), followed by library preparation using Nextera XT DNA Sample Prep Kit (Illumina). 
The yields of cDNA and library amplification were assessed by Qubit (Invitrogen), and the quality 
of the distribution was assessed by Bioanalyzer (Agilent). Libraries were sequenced to produce 
pair-end reads of 100 nucleotides each in a HiSeq 2500 sequencer (Illumina). 
 
Alignment of sequencing reads to fluorescent protein genes in brainbow construct v2.1 
Sequencing reads from each cell were aligned to DNA sequences of the four fluorescent protein 
genes present on brainbow construct v2.1 (Addgene plasmid repository 18723) using STAR 
aligner. Reads that aligned exclusively to one of the sequences were used for counting. Cells 
were assigned a color coding (RFP, YFP, CFP or GFP) according to the greatest number of 
reads matching to one of the fluorescent proteins, or NA when no read aligned to any of the DNA 
sequences. 
 
Alignment to the reference genome  
STAR (STAR_2.5.1b, default parameters) was used to align single-cell sequencing reads to the 
reference genome (mm10, UCSC). Only uniquely aligned reads were used for the following 
analyses. Annotation files for Refseq genes and RepeatMasker defined repeats were 
downloaded from UCSC (February 2015), which contained a total of 24,225 genes and 
5,138,231 repeats, respectively. These annotation files and the uniquely mapped reads in each 
cell were given as input to HTSeq-count (version 0.9.1) for counting of reads associated with 
each gene or repeat.  
 
Principle component analysis 
Principle component analysis was carried out based on all the genes that exhibited FPKM>1 in 
at least one blastomere.  
 
Analysis of variance (ANOVA) analysis 
A generalized linear model was fit to every gene as follows: 
𝑌𝑌𝑖𝑖𝑖𝑖𝑖𝑖
𝑔𝑔 = 𝑢𝑢𝑔𝑔 + 𝛼𝛼𝑖𝑖𝑔𝑔 + 𝛽𝛽𝑖𝑖𝑖𝑖𝑔𝑔 + 𝜀𝜀𝑖𝑖𝑖𝑖𝑖𝑖𝑔𝑔  
where 𝑌𝑌𝑖𝑖𝑖𝑖𝑖𝑖
𝑔𝑔  is the observed expression level (log2(FPKM+1)) of gene 𝑔𝑔 in embryo 𝑖𝑖, lineage 𝑗𝑗 (𝑗𝑗 =0,1), cell 𝑘𝑘; 𝑢𝑢𝑔𝑔 is the average expression level of gene 𝑔𝑔 in all cells; 𝛼𝛼𝑖𝑖𝑔𝑔 is the embryo-effect to 
average expression; 𝛽𝛽𝑖𝑖𝑖𝑖
𝑔𝑔  is the difference of expression levels between the two cell division 
lineages; 𝜀𝜀𝑖𝑖𝑖𝑖𝑖𝑖
𝑔𝑔  is the error term. R package {stats} was used to implement this linear model and 
test for every gene the null hypothesis that no reproducible expression differences between the 
two division, namely 𝛽𝛽𝑖𝑖𝑖𝑖
𝑔𝑔 = 0. To account for multiple hypothesis testing, R package {qvalue} was 
used to compute q-values from ANOVA derived p-values. 
ANOVA analysis for TRENIs was carried out in the same way as for genes, except that index 𝑔𝑔 
in the above generalized linear model was used as the index for TRENIs.    
 
Comparison of lineage variation and embryo variation 
For every gene (𝑔𝑔) we calculated the ratio (𝑟𝑟𝑔𝑔) of lineage sum of squares to combined sum of 
squares of embryo and lineage as    
𝑟𝑟𝑔𝑔 = 𝑆𝑆𝑆𝑆𝑙𝑙𝑖𝑖𝑙𝑙𝑙𝑙𝑙𝑙𝑔𝑔𝑙𝑙 𝑔𝑔 / (𝑆𝑆𝑆𝑆𝑙𝑙𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑔𝑔 + 𝑆𝑆𝑆𝑆𝑙𝑙𝑖𝑖𝑙𝑙𝑙𝑙𝑙𝑙𝑔𝑔𝑙𝑙𝑔𝑔 ). 
The random variable (𝑅𝑅) of ratio of lineage sum of squares and combined sum of squares of 
embryo and lineage was defined as  
𝑅𝑅 = SS𝑙𝑙𝑖𝑖𝑙𝑙𝑙𝑙𝑙𝑙𝑔𝑔𝑙𝑙 (SS𝑙𝑙𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 + SS𝑙𝑙𝑖𝑖𝑙𝑙𝑙𝑙𝑙𝑙𝑔𝑔𝑙𝑙)⁄ . 
 
Identification of novel transcript isoforms  
Novel transcript isoforms were identified by Cufflinks (v2.2.1 with -g parameter) (Trapnell et al., 
2012) with all Rainbow-seq data. Repeat sequences that overlapped with any Refseq annotated 
exons were removed from further analysis. TRENIs were identified by intersecting the remaining 
repeats with novel transcript isoforms using bedtools (2.27.0) (Quinlan and Hall, 2010).   
 
Calculation of junction ratio 
For each repeat sequence (indexed by 𝑖𝑖), HTSeq-count (version 0.9.1) was used to count the 
number of reads mapped to this repeat (𝑇𝑇𝑖𝑖) and the number of reads spanning the junction of 
this repeat and nearby exons (𝑆𝑆𝑖𝑖 ). Junction ratio (𝐽𝐽𝑅𝑅 ) for the 𝑖𝑖P th repeat was calculated as 
𝐽𝐽𝑅𝑅𝑖𝑖 = 𝑇𝑇𝑖𝑖/𝑆𝑆𝑖𝑖.      
 
Analysis of association between repeat families and TRENIs  
Repeat families and the correspondence of individual repeat sequences to repeat families were 
retrieved from RepeatMasker (February 2015). A contingency table was built for each repeat 
family and TRENIs as follows.  
 Contained within TRENIs Not contained in TRENIs 
Is a member of this family 𝑎𝑎 𝑏𝑏 
Not a member 𝑐𝑐 𝑑𝑑 
In the above table 𝑎𝑎, 𝑏𝑏, 𝑐𝑐,𝑑𝑑 are counts of repeat sequences and they sum to the total number 
repeat sequences (5,138,231). Odds ratio representing the degree of association between this 
repeat family and TRENIs was calculated as 
𝑂𝑂𝑅𝑅 =  (𝑎𝑎 × 𝑑𝑑)/(𝑏𝑏 × 𝑐𝑐). 
Ninety five percent confidence interval for odds ratio was calculated as  
𝑒𝑒log(𝑂𝑂𝑂𝑂)±[1.96×𝑆𝑆𝑆𝑆(log(𝑂𝑂𝑂𝑂))], 
where 𝑆𝑆𝑆𝑆(log(𝑂𝑂𝑅𝑅)) = �1𝑎𝑎+1𝑏𝑏+1𝑐𝑐+1𝑑𝑑. 
 
Data and software availability 
We deposited all sequencing data into GEO (GSE106287) for public access.  
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SUPPLEMENTARY FIGURES 
Figure S1. Tamoxifen induced nuclear localization of Cre recombinase, related to Figure 
2. (A) Overview of time and events. Tamoxifen is applied in a 2-hour window (yellow bar) 
at the early 2-cell stage. Microscopic analyses are carried out prior to (*), immediately 
after (**) and 1 hour after tamoxifen treatment (***). (B) Representative embryos (rows). 
Nuclear concentration of CRE was induced at the end of tamoxifen treatment (2nd, 3rd 
rows, two different embryos) and decreased to background level within 1 hour after 
removing tamoxifen (4th row).    
 
 
  
Figure S2. Overview of the single-cell sequencing data, related to Figure 3 and Figure 4. 
(A) Number of uniquely mapped read pairs (y axis) from each single cell (column). Each 
single cell is marked with an embryo number (Embryo), a cell number (Cell) and a binary 
lineage indicator (A or B). N: unresolved. (B) Principle component analysis of lineage 
resolved blastomeres at 4- (red) and 8-cell stages (green), using all genes with FPKM>1 
in a least one blastomere.   
 
 
 
 
  
Figure S3. Histogram of TRENIs’ q-values derived from tests of equivalent expression 
between lineages at 4- (A) and 8-cell (B) stages, based from real data (red) and shuffled 
data (blue), related to Figure 5 and Figure 6. Lower panels: expansion of the range 0 – 
0.4 showing difference of real data and shuffled data in the range of small q-values.  
 
 
  
Figure S4. Tests of equivalent expression between lineages for all expressed repeat 
sequences, related to Figure 5. Repeats’ q-values derived from real (red) and shuffled 
data (blue) exhibited similar histograms, in both 4- (A) and 8-cell (B) stages.  
   
 
 
  
Figure S5. Sensitivity analysis of transposon related novel isoforms (TRENIs), related to 
Figure 5. Odds ratios between TRENIs and each transposon family (columns), calculated 
from only the repeat sequences with junction ratio (JR) > 0.9 (blue) were not very different 
from those calculated from all TRENI embedded repeats (red). Odds ratio was not 
calculated when the TRENIs of a repeat family were fewer than 20. Vertical bars: 95% 
confidence intervals.  
 
 
 
 
  
Figure S6. Novel transcript isoforms of Gata4 and Khdc1a containing murine Alu in 5’ 
UTRs, related to Figure 5 and Figure 6. (A) Expression levels of a novel transcript isoform 
of Gata4 in 4-cell blastomeres. (B) A novel transcript isoform of Khdc1a in 8-cell 
blastomeres. FPKM (y axis) of every blastomere (column) in each embryo (marked by 
embryo number in columns). Shaded columns delineate different embryos. The 
blastomeres of the two lineages are marked with A (red) and B (blue), respectively.  
 
 
  
SUPPLEMENTARY TABLES 
Table S1. Summary of Rainbow-seq data from 4-cell stage blastomeres, related to Figure 
1, Figure 3, and Figure 4. Each blastomere (row) is indexed by embryonic stage (Stage), 
embryo number (Embryo), cell number (Cell), cell division lineage (Lineage), the total 
number of Rainbow-seq reads (# of reads), number (# uniquely mapped) and the 
percentage (Genome mapping rate) of reads uniquely mapped to the mm10 genome, and 
the percentage of reads mapped to the mitochondria genome (Mitochondria mapping 
rate). NA: undetermined. 
Stage Embryo Cell Lineage # of reads # uniquely 
mapped 
Genome 
mapping rate 
Mitochondria 
mapping rate 
4-cell E1 B1 A 21314126 17819219 83.60% 3.66% 
  B2 B 21985294 18088361 82.27% 4.98% 
  B3 A 20235470 17028354 84.15% 1.47% 
  B4 B 23513067 19197409 81.65% 6.23% 
 E2 B1 A 20704467 17146739 82.82% 5.54% 
  B2 B 20058467 16160003 80.56% 7.39% 
  B3 A 18278090 15080241 82.50% 5.29% 
  B4 B 21622583 17630799 81.54% 7.12% 
 E3 B1 A 18775617 16185096 86.20% 2.57% 
  B2 B 18793826 16228376 86.35% 3.96% 
  B3 B 23865180 20424658 85.58% 3.30% 
  B4 A 24696310 20903704 84.64% 4.72% 
 E4 B1 A 25954803 19148778 73.78% 5.02% 
  B2 A 33404660 23079578 69.09% 6.49% 
  B3 B 29530032 21001228 71.12% 7.07% 
  B4 B 31340190 20908747 66.72% 7.94% 
 E5 B1 A 26738657 18974243 70.96% 5.28% 
  B2 B 28170918 16139013 57.29% 30.15% 
  B3 A 28801088 19877650 69.02% 4.79% 
  B4 B 28915622 20154724 69.70% 21.79% 
 E6 B1 A 29629536 22814400 77.00% 3.00% 
  B2 B 12599757 10457443 83.00% 6.21% 
  B3 B 10829517 9033260 83.41% 2.13% 
  B4 A 17688808 14640436 82.77% 1.81% 
 E7 B1 NA 16610220 13908974 83.74% 12.83% 
  B2 NA 17463191 14944165 85.58% 5.43% 
  B3 NA 18099348 15200717 83.98% 7.91% 
  B4 NA 11109883 9425697 84.84% 6.59% 
 E8 B1 NA 32556574 27666944 84.98% 3.47% 
  B2 NA 23739102 20243893 85.28% 2.85% 
  B3 NA 25140202 21316100 84.79% 3.13% 
  B4 NA 28565034 23582751 82.56% 2.94% 
 E9 B1 NA 32027811 26666074 83.26% 8.36% 
  B2 NA 36935316 27818485 75.32% 7.19% 
  B3 NA 44737967 31564011 70.55% 8.46% 
  B4 NA 35022576 26073115 74.45% 13.18% 
Table S2. Summary of Rainbow-seq data from 4-cell stage blastomeres, related to Figure 
1, Figure 3, and Figure 4. Each blastomere (row) is indexed by embryonic stage (Stage), 
embryo number (Embryo), cell number (Cell), cell division lineage (Lineage), the total 
number of Rainbow-seq reads (# of reads), number (# uniquely mapped) and the 
percentage (Genome mapping rate) of reads uniquely mapped to the mm10 genome, and 
the percentage of reads mapped to the mitochondria genome (Mitochondria mapping 
rate). NA: undetermined. 
  
Stage Embryo Cell Lineage # of reads # uniquely 
mapped 
Genome 
mapping rate 
Mitochondria 
mapping rate 
8-cell E10 B1 NA 35510447 30994895 87.28% 2.55% 
  B2 B 31310655 26908056 85.94% 4.20% 
  B3 A 32364998 28069936 86.73% 3.32% 
  B4 B 26879062 23168806 86.20% 3.03% 
  B5 NA 30026238 25835885 86.04% 2.17% 
  B6 A 33728624 28568517 84.70% 2.24% 
  B7 A 29108703 24806968 85.22% 8.06% 
 E11 B1 B 38092133 29663146 77.87% 5.68% 
  B2 NA 30719208 24136791 78.57% 4.52% 
  B3 A 35052929 27408245 78.19% 7.15% 
  B4 A 34218985 25218809 73.70% 7.74% 
  B5 NA 32137812 24846522 77.31% 7.91% 
  B6 A 33420557 27727130 82.96% 7.07% 
  B7 B 3650871 2758113 75.55% 11.98% 
  B8 B 22651287 18476451 81.57% 10.44% 
 E12 B1 B 34015604 29465623 86.62% 3.54% 
  B2 B 24573413 20847753 84.84% 4.69% 
  B3 B 23764288 20252119 85.22% 4.72% 
  B4 A 26254436 21857322 83.25% 4.68% 
  B5 B 29526449 24568457 83.21% 4.23% 
  B6 A 26966760 22102352 81.96% 3.96% 
  B7 A 28616287 21771577 76.08% 5.21% 
  B8 A 22578208 18345514 81.25% 4.97% 
 E13 B1 B 34150397 28982368 84.87% 3.90% 
  B2 A 29319315 25052456 85.45% 3.33% 
  B3 B 31016258 25656830 82.72% 4.22% 
  B4 A 26313847 22461091 85.36% 3.46% 
  B5 A 29808796 25077571 84.13% 2.66% 
  B6 B 31502252 25769136 81.80% 3.55% 
  B7 NA 2967324 1618930 54.56% 0.01% 
  B8 B 41717993 32283499 77.39% 5.65% 
  
 
